U.S. flag

An official website of the United States government

NM_001081.4(CUBN):c.703C>T (p.Arg235Ter) AND Imerslund-Grasbeck syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 5, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001212584.7

Allele description [Variation Report for NM_001081.4(CUBN):c.703C>T (p.Arg235Ter)]

NM_001081.4(CUBN):c.703C>T (p.Arg235Ter)

Genes:
LOC126860871:MED14-independent group 3 enhancer GRCh37_chr10:17157167-17158366 [Gene]
CUBN:cubilin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10p13
Genomic location:
Preferred name:
NM_001081.4(CUBN):c.703C>T (p.Arg235Ter)
HGVS:
  • NC_000010.11:g.17115488G>A
  • NG_008967.1:g.19330C>T
  • NM_001081.4:c.703C>TMANE SELECT
  • NP_001072.2:p.Arg235Ter
  • LRG_540t1:c.703C>T
  • LRG_540:g.19330C>T
  • NC_000010.10:g.17157487G>A
  • NM_001081.3:c.703C>T
Protein change:
R235*
Links:
dbSNP: rs1461982823
NCBI 1000 Genomes Browser:
rs1461982823
Molecular consequence:
  • NM_001081.4:c.703C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Imerslund-Grasbeck syndrome
Synonyms:
ENTEROCYTE COBALAMIN MALABSORPTION; ENTEROCYTE INTRINSIC FACTOR RECEPTOR, DEFECT OF; PERNICIOUS ANEMIA, JUVENILE, DUE TO SELECTIVE INTESTINAL MALABSORPTION OF VITAMIN B12, WITH PROTEINURIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009853; MedGen: C4551825; Orphanet: 35858; OMIM: PS261100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001384172Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 5, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetically heterogeneous selective intestinal malabsorption of vitamin B12: founder effects, consanguinity, and high clinical awareness explain aggregations in Scandinavia and the Middle East.

Tanner SM, Li Z, Bisson R, Acar C, Oner C, Oner R, Cetin M, Abdelaal MA, Ismail EA, Lissens W, Krahe R, Broch H, Gräsbeck R, de la Chapelle A.

Hum Mutat. 2004 Apr;23(4):327-33.

PubMed [citation]
PMID:
15024727

Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns.

Tanner SM, Sturm AC, Baack EC, Liyanarachchi S, de la Chapelle A.

Orphanet J Rare Dis. 2012 Aug 28;7:56. doi: 10.1186/1750-1172-7-56.

PubMed [citation]
PMID:
22929189
PMCID:
PMC3462684
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001384172.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 942574). This variant has not been reported in the literature in individuals affected with CUBN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg235*) in the CUBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CUBN are known to be pathogenic (PMID: 15024727, 22929189).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 7, 2025